AcelRx Pharmaceuticals (ACRX) Institutional Ownership → Claim Your FREE 'AI Income Playbook' Now! (From The Oxford Club) (Ad) Free ACRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for AcelRx Pharmaceuticals (NASDAQ:ACRX)CurrentInstitutional OwnershipPercentage19.79%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$157.94KNumber ofInstitutional Sellers(last 12 months)0 Get ACRX Insider Trade Alerts Want to know when executives and insiders are buying or selling AcelRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACRX Institutional Buying and Selling by Quarter Ad The Oxford ClubClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook. AcelRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/9/2023 Cowen AND Company LLC115,657$67K0.0%N/A0.708% 8/2/2023 Values First Advisors Inc.122,441$136K0.1%+201.7%1.121% 2/15/2023 Tang Capital Management LLC195,000$441K0.1%-49.8%2.618% 2/9/2023 Texas Capital Bank Wealth Management Services Inc.21,500$49K0.0%-95.0%0.289% 1/20/2023 Values First Advisors Inc.36,979$84K0.1%-95.3%0.496% 12/2/2022 Values First Advisors Inc.794,164$166K0.1%+3.5%10.660% Get the Latest News and Ratings for ACRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AcelRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2022 Tang Capital Management LLC388,468$81K0.0%N/A5.273% 11/3/2022 Texas Capital Bank Wealth Management Services Inc.430,000$90K0.0%+437.5%5.837% 10/31/2022 apricus wealth LLC135,500$28K0.0%+3.8%1.839% 7/20/2022 Values First Advisors Inc.767,154$187K0.1%+19.4%0.521% 5/3/2022 Values First Advisors Inc.642,515$183K0.1%+23.7%0.437% 3/10/2022 Values First Advisors Inc.519,274$291K0.2%N/A0.435% 3/9/2022 apricus wealth LLC130,500$73K0.1%N/A0.109% 2/11/2022 Cornerstone Capital Inc.80,000$45K0.0%N/A0.067% 11/15/2021 Rock Springs Capital Management LP3,819,402$3.90M0.1%+0.8%3.205% 11/12/2021 Geode Capital Management LLC985,253$1.00M0.0%-6.2%0.827% 11/10/2021 Mercer Global Advisors Inc. ADV140,226$143K0.0%N/A0.118% 11/10/2021 Robertson Stephens Wealth Management LLC133,840$136K0.0%-39.9%0.112% 11/9/2021 BlackRock Inc.2,240,185$2.29M0.0%-1.1%1.880% 10/19/2021 Edmonds Duncan Registered Investment Advisors LLC26,000$27K0.0%-36.6%0.022% 8/26/2021 Y Intercept Hong Kong Ltd24,209$33K0.0%N/A0.020% 8/17/2021 Millennium Management LLC1,516,715$2.09M0.0%+21.9%1.273% 8/17/2021 Boothbay Fund Management LLC236,742$327K0.0%+18.4%0.199% 8/17/2021 Bridgeway Capital Management LLC509,250$703K0.0%-23.6%0.428% 8/16/2021 LMR Partners LLP47,558$66K0.0%N/A0.040% 8/16/2021 Charles Schwab Investment Management Inc.48,560$68K0.0%-81.5%0.041% 8/16/2021 State Street Corp453,321$626K0.0%-66.8%0.381% 8/16/2021Tibra Equities Europe Ltd246,400$340K0.1%N/A0.207% 8/16/2021 Goldman Sachs Group Inc.107,938$149K0.0%-45.8%0.091% 8/13/2021 Northern Trust Corp219,258$302K0.0%-77.8%0.184% 8/13/2021 MayTech Global Investments LLC51,250$71K0.0%N/A0.043% 8/13/2021 Geode Capital Management LLC1,050,806$1.45M0.0%-37.1%0.882% 8/12/2021 JPMorgan Chase & Co.291,384$402K0.0%+126.7%0.245% 8/12/2021Ergoteles LLC430,539$594K0.0%N/A0.361% 8/11/2021 Bank of New York Mellon Corp34,182$47K0.0%-84.8%0.029% 8/11/2021 BlackRock Inc.2,266,040$3.13M0.0%-70.2%1.903% 8/10/2021 Principal Financial Group Inc.27,460$38K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP384,201$530K0.1%+106.4%0.323% 7/29/2021 Kovack Advisors Inc.41,000$57K0.0%+60.8%0.034% 5/19/2021 Virtu Financial LLC55,798$95K0.0%N/A0.047% Claim Your FREE "AI Income Playbook" Now! (Ad)Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook.5/18/2021 Millennium Management LLC1,243,741$2.11M0.0%+732.6%1.044% 5/18/2021 D. E. Shaw & Co. Inc.5,248,879$8.92M0.0%+479.8%4.407% 5/18/2021 Cornerstone Capital Inc.22,650$39K0.0%-75.7%0.019% 5/18/2021 Morgan Stanley2,535,688$4.31M0.0%+33.7%2.129% 5/18/2021 California State Teachers Retirement System151,428$257K0.0%+24.1%0.127% 5/17/2021 Royal Bank of Canada26,573$46K0.0%-67.7%0.022% 5/17/2021 Price T Rowe Associates Inc. MD101,725$173K0.0%N/A0.085% 5/17/2021 Nuveen Asset Management LLC385,140$655K0.0%+6.0%0.323% 5/17/2021 Goldman Sachs Group Inc.199,204$339K0.0%+74.6%0.167% 5/14/2021 Signature Wealth Management Partners LLC55,000$94K0.1%N/A0.046% 5/14/2021 XTX Topco Ltd31,548$54K0.0%N/A0.026% 5/13/2021 Barclays PLC83,935$142K0.0%+224.9%0.070% 5/13/2021 Bank of New York Mellon Corp224,939$382K0.0%-4.8%0.189% 5/13/2021 Blair William & Co. IL20,850$35K0.0%N/A0.018% 5/12/2021 Northern Trust Corp987,434$1.68M0.0%+10.5%0.829% 5/12/2021 Geode Capital Management LLC1,671,558$2.84M0.0%+36.4%1.403% 5/10/2021 GSA Capital Partners LLP186,161$316K0.1%-8.7%0.156% 5/7/2021 BlackRock Inc.7,614,345$12.95M0.0%+35.0%6.393% 5/7/2021 American International Group Inc.58,512$99K0.0%+25.8%0.049% 5/7/2021 BNP Paribas Arbitrage SA33,088$56K0.0%+95.0%0.028% 5/3/2021 The Manufacturers Life Insurance Company65,428$111K0.0%N/A0.055% 4/30/2021Exane Derivatives64,753$110K0.0%N/A0.054% 2/19/2021 JPMorgan Chase & Co.136,175$169K0.0%+325.7%0.151% 2/19/2021 Edmonds Duncan Registered Investment Advisors LLC41,000$89K0.0%+13.9%0.045% 2/16/2021 ExodusPoint Capital Management LP32,420$40K0.0%N/A0.036% 2/16/2021 Charles Schwab Investment Management Inc.202,469$252K0.0%+8.0%0.224% 2/12/2021 Credit Suisse AG24,724$31K0.0%N/A0.027% 2/11/2021 Northern Trust Corp893,928$1.11M0.0%-0.7%0.988% 2/11/2021 Barclays PLC25,835$32K0.0%-29.3%0.029% 2/10/2021 Rhumbline Advisers87,928$109K0.0%+19.0%0.097% 2/9/2021 Wells Fargo & Company MN316,632$393K0.0%+54.3%0.350% 2/9/2021 Bank of New York Mellon Corp236,256$293K0.0%-2.9%0.261% 2/5/2021 BlackRock Inc.5,640,946$7.00M0.0%+3.4%6.235% 2/5/2021 SG Americas Securities LLC28,580$35K0.0%N/A0.032% 2/4/2021 GSA Capital Partners LLP203,830$253K0.0%+28.9%0.225% 1/19/2021Dfpg Investments LLC52,576$71K0.0%N/A0.058% 12/11/2020 Virtu Financial LLC90,812$129K0.0%+271.6%0.100% 12/1/2020 Townsquare Capital LLC60,076$80K0.0%N/A0.066% 11/13/2020 Morgan Stanley801,424$1.14M0.0%+30.4%0.886% 11/13/2020 Charles Schwab Investment Management Inc.187,409$267K0.0%-8.9%0.207% 11/10/2020 Robertson Stephens Wealth Management LLC212,052$301K0.1%+108.0%0.235% 11/10/2020 State Street Corp1,080,509$1.53M0.0%-1.1%1.196% 11/9/2020 The Manufacturers Life Insurance Company52,665$75K0.0%+72.9%0.058% 11/6/2020 BlackRock Inc.5,455,022$7.75M0.0%-1.0%6.039% 11/6/2020 GSA Capital Partners LLP158,174$225K0.0%+570.6%0.175% 11/5/2020 Wells Fargo & Company MN205,233$291K0.0%-12.8%0.227% 11/4/2020 Edmonds Duncan Registered Investment Advisors LLC36,000$51K0.0%+38.5%0.040% 11/4/2020 Lincoln Capital Corp55,555$79K0.1%+11.1%0.062% 10/30/2020 BNP Paribas Arbitrage SA19,215$27K0.0%+350.3%0.021% 10/29/2020 Cambridge Investment Research Advisors Inc.21,283$30K0.0%+39.3%0.024% Claim Your FREE "AI Income Playbook" Now! (Ad)Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook.9/15/2020 Two Sigma Advisers LP39,900$48K0.0%N/A0.044% 8/25/2020 Nuveen Asset Management LLC307,442$372K0.0%-27.0%0.340% 8/20/2020 Charles Schwab Investment Management Inc.205,616$249K0.0%+7.4%0.228% 8/12/2020 Goldman Sachs Group Inc.67,048$81K0.0%-95.6%0.083% 8/12/2020 Bank of New York Mellon Corp247,090$299K0.0%+6.2%0.306% 8/11/2020 Aigen Investment Management LP33,395$40K0.0%N/A0.041% 8/7/2020 Virtu Financial LLC24,437$30K0.0%N/A0.030% 7/31/2020 Edmonds Duncan Registered Investment Advisors LLC26,000$31K0.0%N/A0.032% 7/31/2020 UBS Group AG37,387$46K0.0%-39.2%0.046% 7/22/2020 Lincoln Capital Corp50,000$61K0.0%+25.0%0.062% (Data available from 1/1/2016 forward) ACRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACRX shares? During the previous two years, the following institutional investors and hedge funds held shares of AcelRx Pharmaceuticals shares: Tang Capital Management LLC ($441K), Values First Advisors Inc. ($136K), Cowen AND Company LLC ($67K), and Texas Capital Bank Wealth Management Services Inc. ($49K), apricus wealth LLC ($28K).Learn more on ACRX's institutional investors. What percentage of AcelRx Pharmaceuticals stock is owned by institutional investors? 19.79% of AcelRx Pharmaceuticals stock is owned by institutional investors. Learn more on ACRX's institutional investor holdings. Which institutional investors have been buying AcelRx Pharmaceuticals stock? The following institutional investors have purchased AcelRx Pharmaceuticals stock in the last 24 months: Tang Capital Management LLC ($388.47K), Texas Capital Bank Wealth Management Services Inc. ($350K), Values First Advisors Inc. ($233.50K), Cowen AND Company LLC ($115.66K), and apricus wealth LLC ($5K). How much institutional buying is happening at AcelRx Pharmaceuticals? Institutional investors have bought a total of 1,092,628 shares in the last 24 months. This purchase volume represents approximately $3.99M in transactions. Which AcelRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold AcelRx Pharmaceuticals stock in the last 24 months: Values First Advisors Inc. ($757.19K), Texas Capital Bank Wealth Management Services Inc. ($408.50K), and Tang Capital Management LLC ($193.47K). How much institutional selling is happening at AcelRx Pharmaceuticals? Institutional investors have sold a total of 1,359,153 shares in the last 24 months. This volume of shares sold represents approximately $3.07M in transactions. Related Companies: Lumos Pharma Institutional Ownership Equillium Institutional Ownership AEON Biopharma Institutional Ownership Leap Therapeutics Institutional Ownership Rockwell Medical Institutional Ownership Reneo Pharmaceuticals Institutional Ownership Theratechnologies Institutional Ownership CalciMedica Institutional Ownership vTv Therapeutics Institutional Ownership BioLineRx Institutional Ownership This page (NASDAQ:ACRX) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AcelRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AcelRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.